Samuel Agresta
Keine laufenden Positionen mehr
Vermögen: 1 $ am 31.01.2024
Karriereverlauf von Samuel Agresta
Ehemalige bekannte Positionen von Samuel Agresta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 | 11.09.2023 |
| INFINITY PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 16.10.2019 | 24.07.2023 |
| Technik-/Wissenschafts-/F&E-Leiter | 07.08.2018 | 16.10.2019 | |
| AGIOS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2011 | 01.08.2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2010 | 01.12.2011 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2007 | 01.12.2010 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Corporate Officer/Principal | 01.08.2004 | 01.11.2010 |
Ausbildung von Samuel Agresta
| Georgetown University | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
| University of South Florida | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 11 |
Operativ
| Chief Tech/Sci/R&D Officer | 5 |
| Graduate Degree | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
- Börse
- Insiders
- Samuel Agresta
- Erfahrung
